Dabur reported a significant beat on the topline and volumes (third highest growth in the past 50 quarters). The Healthcare portfolio fared even better in 2QFY21 (49.3% YoY growth) v/s 1QFY21 (27.7% growth). Notably, Dabur surprised in the Home & Personal Care (HPC) and Food & Beverage (F&B;) segments HPC reported 9.1% YoY growth in 2QFY21 (14.1% decline in 1QFY21), and decline in F&B; was restricted to 3.8% YoY (34.2% decline in 1QFY21 and weak numbers for several preceding quarters). While Healthcare may face a higher base from 3QFY21, the performances of the...